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Since diazepam-ketamine induction sequences in healthy humans cause no significant 
increase in plasma free-norepinephrine and epinephrine, blood pressure and heart 
rate, we have frequently used a diazepam-ketamine pancuronium sequence for 
induction of anesthesia in patients undergoing open-heart surgery. In  order to 
assess objectively the influence of pancuronium on sympathetic activity in cardiac 
patients, plasma free-norepinephrine and free-epinephrine were measured by Vend- 
salu’s method in the arterial blood of 12 patients who were to undergo valve 
replacement or coronary bypass. At the same time, arterial pressure measured by a 
strain-gauge from the radial artery and heart rate measured by ECG were con- 
tinuously recorded during induction with diazepam 0.3 mg/kg, followed 10 min 
later by ketamine 2.0 mg/kg. No significant changes occurred in these parameters 
before pancuronium administration. Plasma free-norepinephrine and free-epine- 
phrine concentrations before and 5 min after pancuronium 0.1 mg/kg given over a 
1-min period were 0.42iz0.05 (mean+s.e.mean) and 0.45k0.05 ng/ml (P>O.l)  
and 0.01 k0.003 and 0.02t0.009 ng/ml (P>O.l), respectively. A significant 
increase in heart rate followed pancuronium administration from 75.0 f 4.0 to 
90.0 f6 .0  beatslmin ( P  50.001). The corresponding systolic and diastolic direct 
arterial pressures were 148.0+9.4/74.0+6.0 and 153.0*8.3/81.0*5.2 mmHg 
(P> 0.05). Although a statistically significant increase in heart rate was observed 
after pancuronium, no significant increase was found in plasma free-norepinephrine, 
epinephrine or direct arterial pressure. 
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Tachycardia following pancuronium in con- 
scious and anesthetized man has been re- 
ported by several authors (FOLDES et al. 1971, 
KELMAN & KENNEDY 197 1, STOELTINC 1972) 
and has been explained on the basis of a 
specific, competitive blockade of cardiac mus- 
carinic receptors in dogs (SAXENA & BONTA 
1971) and by increased sympathetic outflow 
as evidenced by increased plasma norepine- 
phrine concentration, following its admini- 
stration in man (NANA et al. 1973). Recently, 
DOMENECH et al. (1976) have suggested that 
pancuronium increases norepinephrine re- 
lease from the postganglionic adrenergic nerve 
endings in dogs. 
Since we have used pancuronium in car- 
diac patients for several years without inci- 
dent, we were interested in finding out if it 
does indeed cause sympathetic stimulation, as 
reflected in circulatory changes accompanied 
by increased plasma free-norepinephrine and 
epinephrine concentrations. The study by 
NANA et al. (1973) claiming increased cate- 
cholamine levels caused by pancuronium did 
not have a homogenous group of patients, 
lacked a standardized protocol for admini- 
stration of anesthesia, and did not provide for 
eliminating the effect of positioning, endo- 
tracheal intubation and surgical stimulation 
prior to blood sampling. The present study 
was, therefore, designed to control all the 
known variables that may influence sympa- 
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thetic activity, so that any observed changes 
following pancuronium could be ascribed to 
this drug alone. 
MATERIALS AND METHODS 
Twelve adult patients who were scheduled for open- 
heart surgery for valvular replacement (n=8) and 
direct aorto-coronary saphenous vein bypass opera- 
tions (n=4)  were studied. They had not had cortisol 
therapy, propranolol and/or drugs which might alter 
autonomic tone.Themean ageofthepatientswas 5 3 . 0 ~  
(range 29-65 y), mean weight 67.0 kg (40-95 kg), and 
mean height 166 cm (150-182 cm). 
Preanesthetic medication consisted of 0.15 mg/kg 
diazepam and 0.1 5 mg/kg morphine sulfate. Atropine 
was not used in the premedication and/or prior to the 
study. None of the patients were sprayed with a local 
anesthetic prior to or during the study. No skin pre- 
paration, instrumentation (e.g., bladder catheteriza- 
tion, CVP-catheter placement), or positional changes 
were allowed before and/or during the study. There 
was a period of 5-10 rnin between the insertion of an  
arterial plastic catheter and the first arterial baseline 
blood sampling. 
Anesthetic induction was accomplished by the ad- 
ministration of 0.3 mg/kg diazepam intravenously over 
2 min while the patient spontaneously breathed 100% 
oxygen to avoid arterial hypoxemia. Ten minutes after 
diazepam, 2.0 mg/kg ketamine hydrochloride was given 
over a 1-min period into the peripheral intravenous 
line. After an additional 5-min waiting period, 0.1 
mg/kg pancuronium was given intravenously over a 
I-min period. Timing began at  the end of the injection. 
Throughout the study, ventilation was manually assis- 
ted in order to maintain Paco2 between 35-45 mmHg 
and to avoid reduction in Pao, below 90 mmHg. 
Arterial blood gases were monitored frequently 
throughout the study. 
The plasma free-norepinephrine and epinephrine 
were determined in duplicate from the arterial samples 
taken before induction and 15 min after induction but 
before pancuronium, and 5 min after pancuronium but 
prior to intubation by Vendsalu’s method as modified 
by KELSCH et al. (1971). Laboratory personnel were 
not aware of the time of sampling, nor of the sequence 
of samples or the nature of the study. 
Arterial blood pressure was recorded on a Hewlett 
Packard multichannel recorder via a Hewlett Packard 
strain-gauge connected to an indwelling catheter in the 
radial artery. EGG lead I1 or the lead giving the tallest 
R-wave was continuously recorded and utilized in the 
calculation of heart rate at  the time of sampling. 
Patients # 6  and # 10 received continuous i.v. infu- 
sions of sodium nitroprusside throughout the study. 
The paired t-test was used for statistical evaluation 
of the data, a P value of <0.05 being considered 
statistically significant. 
RESULTS 
(1) Plasma free-norepinephrine and epinephrine: No 
significant increase in mean plasma free- 
norepinephrine concentrations was observed 
following induction and following pancuron- 
ium in the 12 patients, as seen in Table 1. 
Mean plasma free-epinephrine concentration 
decreased significantly following induction of 
anesthesia with diazepam and ketamine and 
showed no further significant change following 
pancuronium administration. A marked in- 
crease in norepinephrine and epinephrine 
concentrations occurred only in patient # 2 
with marked Paco2 elevation. Elimination of 
patient # 2  from the statistical evaluation of 
norepinephrine and epinephrine concentra- 
tions resulted in no change in statistical 
significance, although both mean values were 
reduced following pancuronium administra- 
tion. 
( 2 )  Heart rate: Asignificant increase ( P c  0.001) 
in heart rate occurred following pancuronium 
administration, as indicated in Table 2 .  The 
marked increase in heart rate in patients # 2 ,  
6 and 8 ,  accounting for 153%, 128%, and 
12 1 %, respectively, of the baseline value, 
resulted in a large standard deviation. Elimi- 
nation of patients #2, 6 and 8 ,  however, did 
not alter the statistical significance. The mean 
increase in the remaining patients (n=9)  was 
13% of the baseline heart rate, as compared 
to a mean of 19% for the entire group of 
12 patients. No reduction in heart rate was 
observed in any of the patients after pan- 
curonium administration. 
( 3 )  Direct arterial pressure : Diastolic blood 
pressure readings were significantly increased 
( P <  0 .05)  following diazepam-ketamine 
induction over baseline values, while systolic 
pressure readings did not show any significant 
change. Systolic and diastolic pressure read- 
ings following pancuronium were not signi- 
ficantly different from corresponding values 
(P>O.O5) prior to its administration. Deletion 
of patients #6  and 10, who received sodium 
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alter the statistical significance. Patient # 2 
showed the greatest increases in systolic (15%) 
and diastolic (40%) arterial pressures (Table 
2). The mean increases for the group were 
3.7% for systolic pressure and 9.0% for 
diastolic pressure. Decreases greater than 
10% in systolic and diastolic arterial blood 
pressures occurred only in patient # 10 who 
showed a 15% decrease in both, presumably 
due to an i.v. infusion of sodium nitroprusside. 
(4) Arterial bloodgases: Arterial Po, was main- 
tained over 290 mmHg in all the patients 
during the study. Mean arterial Pco2 was 38.5 
k4 .3  mmHg prior to induction, 37.5 If: 7.5 
mmHg after induction but prior to pancur- 
onium, and 37.3h8.2 mmHg 5 min after 
pancuronium administration. In  patient # 2, 
Paco2 rose from a resting level of 39.4 mmHg 
to 47.8 mmHg following induction of anes- 
thesia, and further to 54.6 mmHg 5 min after 
pancuronium administration. 
(5) ECG changes: No arrhythmia occurred 
following the administration of pancuronium. 
(6) Complications: No bronchospasm or evid- 
ence of allergic reactions occurred in any of 
the patients. 
DISCUSSION 
The absence of a significant increase in plasma 
free-norepinephrine and epinephrine, in com- 
bination with the absence of an increase in 
blood pressure following pancuronium, 
indicates that no marked increase in sym- 
pathetic tone was induced by the intravenous 
administration of a full paralyzing dose of' 
pancuronium in this group of cardiac patients. 
This is in contrast to the reported increase in 
catecholamines by NANA et al. (1973). With 
the exception of patients # 3 and # 9, normal 
autonomic tone was present prior to anesthe- 
tic induction with diazepam-ketamine in most 
cardiac patients, as evidenced by their normal 
plasma free-norepinephrine concentrations 
and heart rates (Tables 1 and 2) .  Our ob- 
served mean norepinephrine level, adjusted to 
the mean age, is in agreement with the expec- 
ted norepinephrine concentration of normal 
and hypertensive patients reported by LAKE 
et al. (1977). I t  is interesting to observe that 
even patients # 3  and #9  did not have a 
significant elevation in norepinephrine con- 
centrations following pancuronium admini- 
stration. A marked increase in norepinephrine 
concentration occurred only in patient # 2, 
who had airway obstruction and inadequate 
ventilation throughout the study, resulting in 
a marked increase in PacO2 from 47.8 mmHg 
to 54.6 mmHg, which might have resulted 
in autonomic stimulation. A concomitant 
marked rise in plasma free-epinephrine 
further corroborates our assumption that the 
marked rises in norepinephrine concentration, 
blood pressure and heart rate in this patient 
were the result of adrenomedullary stimulation 
caused by the rapid rise in Paco2 and the 
development of a marked base deficit (BE = 
- 5.4 mEq). 
That the diazepam-ketamine induction 
sequence might have influenced our findings 
may be discounted, since (1) the norepine- 
phrine concentrations before induction and 
before pancuronium administration did not 
differ significantly, and (2) the expected 
increase in catecholamines occurred in patient 
# 2  in prompt response to an  increase in 
Paco2. The possibility that a sympathomime- 
tic effect of pancuronium may be modified 
by diazepam cannot be ruled out completely. 
However, the observed lack of increase in 
norepinephrine and epinephrine definitely 
rules out a marked increase in sympathetic 
tone in this group of patients. 
The possibility that pancuronium causes 
sympathetic stimulation in patients who suf- 
fered major injuries or who are in hemorrhagic 
shock, such as those in the study of' NANA et 
al. (1973), cannot be ruled out by our find- 
ings. Since 40% of the patients of NANA et a]. 
( 1  973) underwent emergency surgery, it was 
not unexpected that the resting norepine- 
phrineand epinephrine levels were abnormally 
elevated, reflecting a major disturbance in 
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autonomic function prior to pancuronium in- 
jection. The large standard deviations in base- 
line catecholamines in their study certainly 
suggest that. Further, since no blood-gas 
determinations were done in their studies, the 
changes in norepinephrine and epinephrine 
concentrations could have been caused by 
hypercarbia and/or inadequate anesthesia. 
The statistically significant increase in 
heart rate following pancuronium injection in 
our study is comparable to that observed by 
FOLDES et al. (1971) in unanesthetized 
healthy volunteers and to the reported rises 
in patients anesthetized with a wide variety 
of agents (SELLICK 1970, SMITH et al. 1970, 
SAXENA & BONTA 1971, BROWN et al. 1973). 
The two main ways by which pancuronium 
may cause the observed tachycardia are: (1) 
sympathetic stimulation, as suggested byNAN.4 
et al. (1973) and more recently DOMENECH 
et al. (1976), or (2) inhibition of the cardiac 
muscarinic receptors, as proposed by SAXENA 
& BONTA (1971). Our inability to show a 
statistically significant rise in plasma free- 
norepinephrine following pancuronium in the 
present series would tend to favor the latter. 
Further evidence against increased sym- 
pathetic activity as a possible cause of tachy- 
cardia are the previous findings of VENDSALU 
(1960), KELSCH et al. (1971) and ZSICMOND et 
al. (1972) that when central sympathetic 
stimulation leads to tachycardia, a prompt 
significant increase in norepinephrine concen- 
tration is consistently observed. However, an 
action of pancuronium on the postganglionic 
nerve endings causing a release of norepine- 
phrineas proposed ~ ~ D O M E N E C H  et al. (1976) 
cannot be ruled out. Our study design does not 
permit the distinct differentiation between 
these possible mechanisms of action of pancu- 
ronium on heart rate. 
Conclusion : Pancuronium does not increase 
mean plasma free-norepinephrine and epine- 
phrine levels when given intravenously follow- 
ing induction of anesthesia with diazepam and 
ketamine in cardiac surgical patients, indicat- 
ing that the observed increase in heart rate 
is more likely to be the result of the inhibition 
of the muscarinic receptors in the heart. None- 
theless, the significant tachycardia elicited by 
pancuronium in some cases should be con- 
sidered when this agent is chosen as a muscle 
relaxant for intubation in cardiac patients. 
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